CCAP

Add to Watchlist

Advanced Chart

0.000

0.000(0.000%)

Overview
Forecast
Valuation

High

15.940

Open

15.810

VWAP

15.41

Vol

416.79K

Mkt Cap

571.49M

Low

15.210

Amount

6.42M

EV/EBITDA(TTM)

10.75

Total Shares

37.06M

1.48B

EV/OCF(TTM)

26.74

P/S(TTM)

3.39

Crescent Capital BDC, Inc. is a specialty finance company focused on lending to middle-market companies. The Company’s investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It invests primarily in secured debt, including first lien, unitranche first lien and second-lien debt, and unsecured debt, including mezzanine and subordinated debt, as well as related equity securities of private United States middle-market companies. It is focused on purchasing interests in loans or make debt investments, either directly from its target companies as primary market or private credit investments (private credit transactions), or primary or secondary market bank loan or high yield transactions in the syndicated market (syndicated loans and bonds). Although its focus is to invest in less liquid private credit transactions. The Company is managed by Crescent Cap Advisors, LLC.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2024Q4

FY2025Q1

FY2025Q2

47.27M

-5.39%

0.560

-8.2%

45.08M

-10.48%

0.525

-16.67%

42.19M

-13.81%

0.513

-12.99%

Estimates Revision

The market is revising No Change the revenue expectations for Crescent Capital BDC, Inc. (CCAP) for FY2024, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -20.79%.

Revenue Estimates for FY2024

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2024

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-20.79%

In Past 3 Month

3 Analyst Rating

22.11% Upside

Wall Street analysts forecast CCAP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CCAP is 18.83 USD with a low forecast of 18.00 USD and a high forecast of 20.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

1 Hold

0 Sell

Moderate Buy

22.11% Upside

Current: 15.420

Low

18.00

Averages

18.83

High

20.00

22.11% Upside

Current: 15.420

Low

18.00

Averages

18.83

High

20.00

Wells Fargo

Finian O'Shea

Hold

Maintains

$18 → $16

2025-04-28

Reason

Wells Fargo

Finian O'Shea

Price Target

$18 → $16

2025-04-28

Maintains

Hold

Reason

Keefe, Bruyette & Woods

Ryan Lynch

Buy

Maintains

$20 → $19

2025-04-08

Reason

Keefe, Bruyette & Woods

Ryan Lynch

Price Target

$20 → $19

2025-04-08

Maintains

Buy

Reason

Keefe Bruyette analyst Paul Johnson lowered the firm's price target on Crescent Capital BDC to $18.50 from $20 and keeps an Outperform rating on the shares.

Wells Fargo

Finian O'Shea

Hold

Maintains

$19 → $18

2025-02-21

Reason

Wells Fargo

Finian O'Shea

Price Target

$19 → $18

2025-02-21

Maintains

Hold

Reason

Wells Fargo

Finian O'Shea

Hold

Maintains

$18 → $19

2025-01-29

Reason

Wells Fargo

Finian O'Shea

Price Target

$18 → $19

2025-01-29

Maintains

Hold

Reason

Keefe, Bruyette & Woods

Ryan Lynch

Buy

Maintains

$19 → $20

2024-11-25

Reason

Keefe, Bruyette & Woods

Ryan Lynch

Price Target

$19 → $20

2024-11-25

Maintains

Buy

Reason

Keefe Bruyette raised the firm's price target on Crescent Capital BDC to $20 from $19 and keeps an Outperform rating on the shares. The firm notes the company reported a large beat to its estimates and consensus, driven by accelerated OID from payoffs and higher fee income. However, NAV declined -0.5% and credit metrics declined slightly. Keefe Bruyette cites the continued progress on rotating out of the FCRD portfolio for the price target change, but says it is reducing estimates due to a lower base rate projections and tighter portfolio spread.

Ladenburg Thalmann

Mickey Schleien

Strong Buy

Initiates

$20

2024-09-30

Reason

Ladenburg Thalmann

Mickey Schleien

Price Target

$20

2024-09-30

Initiates

Strong Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Crescent Capital BDC Inc (CCAP.O) is 7.17, compared to its 5-year average forward P/E of 8.47. For a more detailed relative valuation and DCF analysis to assess Crescent Capital BDC Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair

5Y Average PE

8.47

Current PE

7.17

Overvalued PE

10.11

Undervalued PE

6.83

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

4.01

Current PS

3.19

Overvalued PS

4.95

Undervalued PS

3.08